AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 835531 — intervention group
Group type: COMPARATOR
Intervention: Sodium chloride
Number of subjects: 450
Study 835531 — intervention group
Group type: EXPERIMENTAL
Intervention: Boric acid-sodium borate solution
Number of subjects: 450
Study 835531 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-birth-weight infants
Number of subjects: 450
Study 31733045 — intervention group
Group type: EXPERIMENTAL
Intervention: Podiatry intervention (3 visits, foot orthoses, exercise, manual therapy, advice)
Number of subjects: 30
Study 31733045 — intervention group
Group type: COMPARATOR
Intervention: Usual GP care (1 visit, medication advice/prescription, same advice as podiatry group)
Number of subjects: 30
Study 31733045 — intervention group
Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 30
Study 30791102 — intervention group
Group type: EXPERIMENTAL
Intervention: Dupilumab 300 mg every 2 weeks (q2w)
Number of subjects: 449
Study 30791102 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 449
Study 30312162 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture with standard-of-care pain treatment
Number of subjects: 425
Study 30312162 — intervention group
Group type: COMPARATOR
Intervention: Standard-of-care treatment only
Number of subjects: 425
Study 27415153 — intervention group
Group type: EXPERIMENTAL
Intervention: Locally produced, cereal-based, ready-to-use supplementary food for five months
Number of subjects: 500
Study 27415153 — intervention group
Group type: COMPARATOR
Intervention: Well-nourished controls
Number of subjects: 500
Study 24217275 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive exercise training (IG)
Number of subjects: 148
Study 24217275 — intervention group
Group type: COMPARATOR
Intervention: Usual care treatment (CG)
Number of subjects: 148
Study 21604065 — intervention group
Group type: EXPERIMENTAL
Intervention: Audio Computer-Assisted Self-Interview (ACASI)
Number of subjects: 274
Study 21604065 — intervention group
Group type: COMPARATOR
Intervention: Face-to-Face (FTF) interview
Number of subjects: 274
Study 21604065 — intervention group
Group type: EXPERIMENTAL
Intervention: ACASI
Number of subjects: 274
Study 21604065 — intervention group
Group type: COMPARATOR
Intervention: FTF
Number of subjects: 274
Study 20096179 — intervention group
Group type: EXPERIMENTAL
Intervention: Tension-free vaginal tape (TVT)
Number of subjects: 49
Study 20096179 — intervention group
Group type: COMPARATOR
Intervention: Burch colposuspension (CS)
Number of subjects: 49
Study 17704031 — intervention group
Group type: EXPERIMENTAL
Intervention: Individual counseling program (INT)
Number of subjects: 233
Study 15863117 — intervention group
Group type: EXPERIMENTAL
Intervention: Bicycle ergometer trials at 118 W in tops and drops and at 300+/‐82.4 W in top handlebar positions
Number of subjects: 0
Study 15863117 — intervention group
Group type: EXPERIMENTAL
Intervention: Bicycle ergometer trials
Number of subjects: 0
Study 12092923 — intervention group
Group type: EXPERIMENTAL
Intervention: HIV/AIDS behavioral change intervention
Number of subjects: 58
Study 12092923 — intervention group
Group type: EXPERIMENTAL
Intervention: Material assistance
Number of subjects: 58
Study 12092923 — intervention group
Group type: EXPERIMENTAL
Intervention: Trial acceptance
Number of subjects: 58
Study 12092923 — intervention group
Group type: EXPERIMENTAL
Intervention: Sensitive mobilization and ongoing communication
Number of subjects: 58
Study 10445535 — intervention group
Group type: EXPERIMENTAL
Intervention: Serial IgG antibody determinations
Number of subjects: 83
Study 10445535 — intervention group
Group type: EXPERIMENTAL
Intervention: Parallel IgG antibody determinations
Number of subjects: 83
Study 10445535 — intervention group
Group type: EXPERIMENTAL
Intervention: Cut-off for H. pylori eradication
Number of subjects: 83
Study 7758262 — intervention group
Group type: EXPERIMENTAL
Intervention: Simvastatin
Number of subjects: 44
Study 7758262 — intervention group
Group type: EXPERIMENTAL
Intervention: Bezafibrate
Number of subjects: 44
Study 7758262 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 44
Study 2179511 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasonic instruments
Number of subjects: 31
Study 2179511 — intervention group
Group type: COMPARATOR
Intervention: Hand instruments
Number of subjects: 31
Study 2179511 — intervention group
Group type: EXPERIMENTAL
Intervention: Both instruments
Number of subjects: 31
Study 465432 — intervention group
Group type: EXPERIMENTAL
Intervention: Iron fortification of food providing 10 mg elemental Fe/child per day
Number of subjects: 24
Study 465432 — intervention group
Group type: EXPERIMENTAL
Intervention: Ferrous sulphate (5 mg) mixed in one meal
Number of subjects: 24
Study 465432 — intervention group
Group type: EXPERIMENTAL
Intervention: Ferrous sulphate (3.3 mg) given with each of three meals over 2 days
Number of subjects: 24
Study 465432 — intervention group
Group type: EXPERIMENTAL
Intervention: Ferrous ascorbate (test dose)
Number of subjects: 24
Study 30859741 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined in-office whitening (6% hydrogen peroxide) + at-home whitening (16% carbamide peroxide for 2 weeks)
Number of subjects: 30
Study 30859741 — intervention group
Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 30
Study 29096672 — intervention group
Group type: EXPERIMENTAL
Intervention: Yoga (90-min session weekly for 8 weeks)
Number of subjects: 126
Study 29096672 — intervention group
Group type: COMPARATOR
Intervention: Stretching and resistance exercises (60-min session weekly for 8 weeks)
Number of subjects: 126
Study 24978836 — intervention group
Group type: EXPERIMENTAL
Intervention: Repeated sprints in hypoxia (RSH; FIO2 = 14.3%)
Number of subjects: 16
Study 24978836 — intervention group
Group type: COMPARATOR
Intervention: Repeated sprints in normoxia (RSN; FIO2 = 21.0%)
Number of subjects: 16
Study 24978836 — intervention group
Group type: EXPERIMENTAL
Intervention: RSH
Number of subjects: 16
Study 24978836 — intervention group
Group type: COMPARATOR
Intervention: RSN
Number of subjects: 16
Study 24978836 — intervention group
Group type: EXPERIMENTAL
Intervention: Both RSH and RSN
Number of subjects: 16
Study 24268212 — intervention group
Group type: EXPERIMENTAL
Intervention: Sitagliptin
Number of subjects: 14000
Study 24268212 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14000
Study 21301766 — intervention group
Group type: EXPERIMENTAL
Intervention: Acaricides and environmental anti house dust mite (HDM) measures
Number of subjects: 98
Study 21301766 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypersensitivity to Dermatophagoides pteronyssinus and D. farinae
Number of subjects: 98
Study 21301766 — intervention group
Group type: EXPERIMENTAL
Intervention: Skin prick test (SPT)
Number of subjects: 98
Study 21301766 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypersensitivity to HDM
Number of subjects: 98
Study 19772596 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured weekly SMS messaging
Number of subjects: 0
Study 19772596 — intervention group
Group type: COMPARATOR
Intervention: Standard care support mechanisms
Number of subjects: 0
Study 17963859 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral contraceptive pills (OCs) initiation
Number of subjects: 757
Study 17963859 — intervention group
Group type: COMPARATOR
Intervention: Expected rate for U.S. women aged 15‐44
Number of subjects: 757
Study 15020159 — intervention group
Group type: EXPERIMENTAL
Intervention: Titanium plates and Ti-6Al-4V screws
Number of subjects: 0
Study 15020159 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydroxyapatite (Osprovit) grafts
Number of subjects: 0
Study 12057729 — intervention group
Group type: EXPERIMENTAL
Intervention: Bravelle s.c.
Number of subjects: 177
Study 12057729 — intervention group
Group type: EXPERIMENTAL
Intervention: Bravelle i.m.
Number of subjects: 177
Study 12057729 — intervention group
Group type: COMPARATOR
Intervention: Follistim s.c.
Number of subjects: 177
Study 9467443 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonmechanical excimer laser trephination
Number of subjects: 52
Study 9467443 — intervention group
Group type: COMPARATOR
Intervention: Mechanical trephination
Number of subjects: 52
Study 8534077 — intervention group
Group type: EXPERIMENTAL
Intervention: Humorous audiotape for 20 minutes
Number of subjects: 46
Study 8534077 — intervention group
Group type: EXPERIMENTAL
Intervention: Tranquil music audiotape for 20 minutes
Number of subjects: 46
Study 8534077 — intervention group
Group type: COMPARATOR
Intervention: No intervention (control group)
Number of subjects: 46
Study 2617244 — intervention group
Group type: EXPERIMENTAL
Intervention: Indomethacin 25 mg i.v.
Number of subjects: 10
Study 2617244 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 338392 — intervention group
Group type: EXPERIMENTAL
Intervention: Buprenorphine 0.3 mg
Number of subjects: 0
Study 338392 — intervention group
Group type: COMPARATOR
Intervention: Morphine 10 mg
Number of subjects: 0
Study 28735272 — intervention group
Group type: EXPERIMENTAL
Intervention: Perceived low nicotine cigarettes
Number of subjects: 0
Study 28735272 — intervention group
Group type: EXPERIMENTAL
Intervention: Perceived moderate nicotine cigarettes
Number of subjects: 0
Study 28735272 — intervention group
Group type: EXPERIMENTAL
Intervention: Perceived high/very high nicotine cigarettes
Number of subjects: 0
Study 28735272 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower perceived risk of developing other cancers and heart disease
Number of subjects: 0
Study 27217321 — intervention group
Group type: EXPERIMENTAL
Intervention: Parenting intervention
Number of subjects: 25
Study 24231633 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral stress management
Number of subjects: 531
Study 24231633 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardiovascular fitness
Number of subjects: 531
Study 24231633 — intervention group
Group type: EXPERIMENTAL
Intervention: Generalized physical activity
Number of subjects: 531
Study 24231633 — intervention group
Group type: COMPARATOR
Intervention: Control with no intervention
Number of subjects: 531
Study 22284315 — intervention group
Group type: EXPERIMENTAL
Intervention: PCA with tramadol (1.0 mg/kg loading dose, 10 mg metoclopramide, 0.3 mg/kg/mL every 5 minutes)
Number of subjects: 30
Study 22284315 — intervention group
Group type: COMPARATOR
Intervention: PCA with remifentanil (placebo 100 mL 0.9% normal saline, 0.4 μg/kg/mL every two minutes)
Number of subjects: 30
Study 22284315 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 30
Study 22254070 — intervention group
Group type: EXPERIMENTAL
Intervention: Annual feedback on calcium intake and strategies to improve intake
Number of subjects: 2000
Study 22254070 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline calcium intake assessment
Number of subjects: 2000
Study 17313719 — intervention group
Group type: EXPERIMENTAL
Intervention: Nambour FFQ
Number of subjects: 43
Study 16285948 — intervention group
Group type: EXPERIMENTAL
Intervention: Ursodeoxycholic acid (17 to 23 mg/kg body weight per day)
Number of subjects: 219
Study 16285948 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 219
Study 11929950 — intervention group
Group type: EXPERIMENTAL
Intervention: Estrogen replacement therapy (ERT)
Number of subjects: 655
Study 11929950 — intervention group
Group type: EXPERIMENTAL
Intervention: Hormone replacement therapy with sequentially added progestins (HRTsp)
Number of subjects: 655
Study 11929950 — intervention group
Group type: COMPARATOR
Intervention: Hormone replacement therapy with continuously added progestins (HRTcp)
Number of subjects: 655
Study 11929950 — intervention group
Group type: EXPERIMENTAL
Intervention: HRTsp ever users
Number of subjects: 655
Study 11929950 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-potency estrogens (oral)
Number of subjects: 655
Study 11929950 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-potency estrogens (vaginal)
Number of subjects: 655
Study 9485239 — intervention group
Group type: EXPERIMENTAL
Intervention: Minimally invasive coronary artery bypass grafting
Number of subjects: 62
Study 9485239 — intervention group
Group type: COMPARATOR
Intervention: Conventional coronary artery bypass grafting with cardiopulmonary bypass
Number of subjects: 62
Study 7638806 — intervention group
Group type: EXPERIMENTAL
Intervention: SmartMist device at medium/early setting (medium flow, early cumulative inspired volume)
Number of subjects: 9
Study 7638806 — intervention group
Group type: EXPERIMENTAL
Intervention: SmartMist device at slow/early setting (slow flow, early cumulative inspired volume)
Number of subjects: 9
Study 7638806 — intervention group
Group type: EXPERIMENTAL
Intervention: SmartMist device at fast/late setting (fast flow, late cumulative inspired volume)
Number of subjects: 9
Study 7638806 — intervention group
Group type: EXPERIMENTAL
Intervention: SmartMist device at medium/early setting
Number of subjects: 9
Study 7638806 — intervention group
Group type: EXPERIMENTAL
Intervention: SmartMist device at slow/early setting
Number of subjects: 9
Study 7638806 — intervention group
Group type: EXPERIMENTAL
Intervention: All modes of inhalation studied
Number of subjects: 9
Study 2572036 — intervention group
Group type: EXPERIMENTAL
Intervention: Broxaterol (oral route, total dose 1.675 mg)
Number of subjects: 8
Study 2572036 — intervention group
Group type: EXPERIMENTAL
Intervention: Broxaterol (inhaled route, total dose 1.5 mg)
Number of subjects: 8
Study 2572036 — intervention group
Group type: COMPARATOR
Intervention: Salbutamol (oral route, total dose 26 mg)
Number of subjects: 8
Study 2572036 — intervention group
Group type: COMPARATOR
Intervention: Salbutamol (inhaled route, total dose 1.5 mg)
Number of subjects: 8
Study 2572036 — intervention group
Group type: EXPERIMENTAL
Intervention: Broxaterol (oral route)
Number of subjects: 8
Study 2572036 — intervention group
Group type: EXPERIMENTAL
Intervention: Broxaterol (inhaled route)
Number of subjects: 8
Study 319271 — intervention group
Group type: EXPERIMENTAL
Intervention: ticrynafen
Number of subjects: 20
Study 319271 — intervention group
Group type: COMPARATOR
Intervention: hydrochlorothiazide
Number of subjects: 20
Study 31843335 — intervention group
Group type: EXPERIMENTAL
Intervention: Abiraterone acetate plus androgen deprivation therapy (AAP + ADT)
Number of subjects: 1199
Study 31843335 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus androgen deprivation therapy (PBO + ADT)
Number of subjects: 1199
Study 28121978 — intervention group
Group type: EXPERIMENTAL
Intervention: Vibrating Cold Device (VCD)
Number of subjects: 224
Study 28121978 — intervention group
Group type: COMPARATOR
Intervention: Topical Lidocaine cream (TL)
Number of subjects: 224
Study 27561376 — intervention group
Group type: EXPERIMENTAL
Intervention: Rivastigmine patch (applied from 3 days before to 7 days after surgery)
Number of subjects: 62
Study 27561376 — intervention group
Group type: COMPARATOR
Intervention: Control group (no rivastigmine patch)
Number of subjects: 62
Study 27561376 — intervention group
Group type: EXPERIMENTAL
Intervention: Rivastigmine patch
Number of subjects: 62
Study 27561376 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 62
Study 25326135 — intervention group
Group type: EXPERIMENTAL
Intervention: Bioimpedance spectroscopy (BIS)
Number of subjects: 71
Study 25326135 — intervention group
Group type: COMPARATOR
Intervention: Bromide dilution
Number of subjects: 71
Study 25326135 — intervention group
Group type: COMPARATOR
Intervention: Dual energy X‐ray absorptiometry (DXA)
Number of subjects: 71
Study 23242542 — intervention group
Group type: EXPERIMENTAL
Intervention: HPV-16/18 AS04-adjuvanted vaccine
Number of subjects: 676
Study 23242542 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 676
Study 21364458 — intervention group
Group type: EXPERIMENTAL
Intervention: Tranexamic acid (TXA)
Number of subjects: 43
Study 21364458 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 43
Study 18397386 — intervention group
Group type: COMPARATOR
Intervention: Ribavirin 800 mg/day
Number of subjects: 891
Study 18397386 — intervention group
Group type: EXPERIMENTAL
Intervention: Ribavirin 1000/1200 mg/day
Number of subjects: 891
Study 17159017 — intervention group
Group type: EXPERIMENTAL
Intervention: Caloric restriction (CR)
Number of subjects: 48
Study 17159017 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise (EX)
Number of subjects: 48
Study 17159017 — intervention group
Group type: COMPARATOR
Intervention: Healthy lifestyle (HL) control group
Number of subjects: 48
Study 12669750 — intervention group
Group type: EXPERIMENTAL
Intervention: Response selection during go trials
Number of subjects: 0
Study 12669750 — intervention group
Group type: EXPERIMENTAL
Intervention: Response selection
Number of subjects: 0
Study 12669750 — intervention group
Group type: EXPERIMENTAL
Intervention: Preparation time in go trials
Number of subjects: 0
Study 11127213 — intervention group
Group type: EXPERIMENTAL
Intervention: HRT (2 mg of estradiol valerate and 1 mg of cyproterone acetate with or without vitamin D3, 100-300 IU + 93 mg calcium as lactate per day)
Number of subjects: 331
Study 11127213 — intervention group
Group type: COMPARATOR
Intervention: Non-HRT (93 mg of calcium alone or in combination with vitamin D3, 100-300 IU/day)
Number of subjects: 331
Study 9192993 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylactic intracavitary treatment with interferon alpha 2b (IFN‐alpha‐2b)
Number of subjects: 0
Study 9192993 — intervention group
Group type: COMPARATOR
Intervention: Untreated patients and healthy control subjects
Number of subjects: 0
Study 7948351 — intervention group
Group type: EXPERIMENTAL
Intervention: 75% lipid/25% glucose regimen
Number of subjects: 14
Study 7948351 — intervention group
Group type: COMPARATOR
Intervention: Glucose alone
Number of subjects: 14
Study 3295446 — intervention group
Group type: EXPERIMENTAL
Intervention: MRI at 0.15 T
Number of subjects: 157
Study 3295446 — intervention group
Group type: COMPARATOR
Intervention: Sham-imaged
Number of subjects: 157
Study 3295446 — intervention group
Group type: COMPARATOR
Intervention: Nonimaged control
Number of subjects: 157
Study 29086103 — intervention group
Group type: EXPERIMENTAL
Intervention: New Forest Parenting Programme (NFPP) - 12-week individual, home-delivered ADHD parent training program
Number of subjects: 0
Study 29086103 — intervention group
Group type: EXPERIMENTAL
Intervention: Incredible Years (IY) - 12-week group-based parent training program
Number of subjects: 0
Study 29086103 — intervention group
Group type: COMPARATOR
Intervention: Treatment as Usual (TAU)
Number of subjects: 0
Study 24747996 — intervention group
Group type: EXPERIMENTAL
Intervention: Workshop
Number of subjects: 503
Study 24747996 — intervention group
Group type: COMPARATOR
Intervention: Lecture
Number of subjects: 503
Study 24747996 — intervention group
Group type: COMPARATOR
Intervention: Pamphlet
Number of subjects: 503
Study 23140031 — intervention group
Group type: EXPERIMENTAL
Intervention: Pelvic Floor Muscle Training (PFMT)
Number of subjects: 28
Study 23140031 — intervention group
Group type: EXPERIMENTAL
Intervention: Rectal Balloon Training (RBT)
Number of subjects: 28
Study 23140031 — intervention group
Group type: COMPARATOR
Intervention: Control (PFMT)
Number of subjects: 28
Study 23140031 — intervention group
Group type: COMPARATOR
Intervention: Control (RBT)
Number of subjects: 28
Study 20547275 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced intervention: brochure, FOBT plus telephone counseling (n=768)
Number of subjects: 1358
Study 20547275 — intervention group
Group type: EXPERIMENTAL
Intervention: Basic intervention: culturally tailored brochure plus FOBT kit (n=765)
Number of subjects: 1358
Study 20547275 — intervention group
Group type: COMPARATOR
Intervention: Usual care (n=256)
Number of subjects: 1358
Study 18537189 — intervention group
Group type: EXPERIMENTAL
Intervention: Entecavir 1 mg
Number of subjects: 286
Study 18537189 — intervention group
Group type: COMPARATOR
Intervention: Lamivudine 100 mg
Number of subjects: 286
Study 15643531 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluid ingestion during 3‐h cycling exercise
Number of subjects: 16
Study 15643531 — intervention group
Group type: COMPARATOR
Intervention: No fluid ingestion during 3‐h cycling exercise
Number of subjects: 16
Study 15643531 — intervention group
Group type: COMPARATOR
Intervention: No exercise and no fluid ingestion
Number of subjects: 16
Study 12860920 — intervention group
Group type: EXPERIMENTAL
Intervention: ICD recipients
Number of subjects: 85
Study 12860920 — intervention group
Group type: EXPERIMENTAL
Intervention: Controlled breathing frequency of 0.10 Hz
Number of subjects: 85
Study 12860920 — intervention group
Group type: COMPARATOR
Intervention: Young healthy individuals
Number of subjects: 85
Study 10382913 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower limb surgery (hip and knee release, aponeurectomy of the iliotibial band, Achilles tendon lengthening)
Number of subjects: 213
Study 10382913 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower limb surgery
Number of subjects: 213
Study 10382913 — intervention group
Group type: COMPARATOR
Intervention: Control group (natural history, non-operated DMD patients)
Number of subjects: 213
Study 7720152 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose midazolam (0.03 mg.kg-1)
Number of subjects: 64
Study 7720152 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose midazolam (0.06 mg.kg-1)
Number of subjects: 64
Study 7720152 — intervention group
Group type: EXPERIMENTAL
Intervention: Midazolam (both doses)
Number of subjects: 64
Study 7720152 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 64
Study 2252879 — intervention group
Group type: EXPERIMENTAL
Intervention: Large loop excision of the transformation zone (LLETZ)
Number of subjects: 199
Study 2252879 — intervention group
Group type: COMPARATOR
Intervention: Carbon dioxide laser vaporization
Number of subjects: 199
Study 6103906 — intervention group
Group type: EXPERIMENTAL
Intervention: Fenoterol hydrobromide, 1 mg/ml, nasal spray (204 to 576 microgram)
Number of subjects: 11
Study 6103906 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study 31835994 — intervention group
Group type: EXPERIMENTAL
Intervention: Posterior sciatic nerve block (group P)
Number of subjects: 58
Study 31835994 — intervention group
Group type: COMPARATOR
Intervention: Anterior sciatic nerve block (group A)
Number of subjects: 58
Study 28438273 — intervention group
Group type: EXPERIMENTAL
Intervention: Antenatal yoga program (1‐h supervised yoga class, three times a week, starting at 26 weeks gestation)
Number of subjects: 60
Study 28438273 — intervention group
Group type: EXPERIMENTAL
Intervention: Antenatal yoga program
Number of subjects: 60
Study 28438273 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 60
Study 25542917 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine lozenges
Number of subjects: 120